{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:09:30Z","timestamp":1790680170565,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s11033-023-08338-z","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T11:02:33Z","timestamp":1678532553000},"page":"4723-4728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with metabolically healthy obesity"],"prefix":"10.1007","volume":"50","author":[{"given":"Fernando","family":"Guerrero-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco X.","family":"Castellanos-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Salas-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco G.","family":"Morales-Gurrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma Cristina","family":"Salas-Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3617-4921","authenticated-orcid":false,"given":"Luis E.","family":"Simental-Mend\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,11]]},"reference":[{"key":"8338_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/metabo10020048","volume":"10","author":"I Brand\u00e3o","year":"2020","unstructured":"Brand\u00e3o I, Martins MJ, Monteiro R (2020) Metabolically healthy obesity\u2014heterogeneity in definitions and unconventional factors. Metabolites 10:48. https:\/\/doi.org\/10.3390\/metabo10020048","journal-title":"Metabolites"},{"key":"8338_CR2","doi-asserted-by":"publisher","first-page":"e3384","DOI":"10.1097\/MD.0000000000003384","volume":"95","author":"NH Kim","year":"2016","unstructured":"Kim NH, Seo JA, Cho H et al (2016) Risk of the Development of Diabetes and Cardiovascular Disease in metabolically healthy obese people. Med (Baltim) 95:e3384. https:\/\/doi.org\/10.1097\/MD.0000000000003384","journal-title":"Med (Baltim)"},{"key":"8338_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","volume":"377","author":"MM Finucane","year":"2011","unstructured":"Finucane MM, Stevens GA, Cowan MJ et al (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9\u00b71 million participants. Lancet (London England) 377:557\u2013567. https:\/\/doi.org\/10.1016\/S0140-6736(10)62037-5","journal-title":"Lancet (London England)"},{"key":"8338_CR4","doi-asserted-by":"publisher","unstructured":"Lin H, Zhang L, Zheng R, Zheng Y (2017) The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: a PRISMA-compliant article. Med (Baltim) 96. https:\/\/doi.org\/10.1097\/MD.0000000000008838","DOI":"10.1097\/MD.0000000000008838"},{"key":"8338_CR5","doi-asserted-by":"publisher","unstructured":"Schmidt FM, Weschenfelder J, Sander C et al (2015) Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS ONE 10. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0121971","DOI":"10.1371\/JOURNAL.PONE.0121971"},{"key":"8338_CR6","doi-asserted-by":"publisher","unstructured":"van Wijk DF, Boekholdt SM, Arsenault BJ et al (2016) C-reactive protein identifies low-risk metabolically healthy obese persons: the european prospective investigation of cancer-norfolk prospective population study. J Am Heart Assoc 5. https:\/\/doi.org\/10.1161\/JAHA.115.002823","DOI":"10.1161\/JAHA.115.002823"},{"key":"8338_CR7","doi-asserted-by":"publisher","unstructured":"Phillips CM, Perry IJ (2013) Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab 98. https:\/\/doi.org\/10.1210\/JC.2013-2038","DOI":"10.1210\/JC.2013-2038"},{"key":"8338_CR8","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1210\/JC.2005-0482","volume":"90","author":"AD Karelis","year":"2005","unstructured":"Karelis AD, Faraj M, Bastard JP et al (2005) The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90:4145\u20134150. https:\/\/doi.org\/10.1210\/JC.2005-0482","journal-title":"J Clin Endocrinol Metab"},{"key":"8338_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/13813455.2011.562514","volume":"117","author":"M Fresno","year":"2011","unstructured":"Fresno M, Alvarez R, Cuesta N (2011) Toll-like receptors, inflammation, metabolism and obesity. Arch Physiol Biochem 117:151\u2013164. https:\/\/doi.org\/10.3109\/13813455.2011.562514","journal-title":"Arch Physiol Biochem"},{"key":"8338_CR10","doi-asserted-by":"publisher","unstructured":"Latty S, Sakai J, Hopkins L et al (2018) Activation of toll-like receptors nucleates assembly of the MyDDosome signaling hub. Elife 7. https:\/\/doi.org\/10.7554\/ELIFE.31377","DOI":"10.7554\/ELIFE.31377"},{"key":"8338_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/OBY.2008.25","volume":"16","author":"OI Vitseva","year":"2008","unstructured":"Vitseva OI, Tanriverdi K, Tchkonia TT et al (2008) Inducible toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obes (Silver Spring) 16:932\u2013937. https:\/\/doi.org\/10.1038\/OBY.2008.25","journal-title":"Obes (Silver Spring)"},{"key":"8338_CR12","doi-asserted-by":"publisher","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association (2009) Harmonizing the metabolic syndrome: a joint interim ; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640\u20131645. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192644","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"8338_CR13","doi-asserted-by":"publisher","unstructured":"Dinh KM, Kaspersen KA, Mikkelsen S et al (2019) Low-grade inflammation is negatively associated with physical health-related quality of life in healthy individuals: results from the danish blood Donor Study (DBDS). PLoS ONE 14. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0214468","DOI":"10.1371\/JOURNAL.PONE.0214468"},{"key":"8338_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1373\/49.4.666","volume":"49","author":"N Rifai","year":"2003","unstructured":"Rifai N, Ridker PM (2003) Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem 49:666\u2013669. https:\/\/doi.org\/10.1373\/49.4.666","journal-title":"Clin Chem"},{"key":"8338_CR15","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/JC.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M et al (2010) The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 95:3347\u20133351. https:\/\/doi.org\/10.1210\/JC.2010-0288","journal-title":"J Clin Endocrinol Metab"},{"key":"8338_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/MET.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299\u2013304. https:\/\/doi.org\/10.1089\/MET.2008.0034","journal-title":"Metab Syndr Relat Disord"},{"key":"8338_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/JCSM.12159","volume":"8","author":"MC Gonzalez","year":"2017","unstructured":"Gonzalez MC, Heymsfield SB (2017) Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating? J Cachexia Sarcopenia Muscle 8:187\u2013189. https:\/\/doi.org\/10.1002\/JCSM.12159","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"8338_CR18","doi-asserted-by":"publisher","unstructured":"Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertens (Dallas, Tex 1979) 42:1206\u20131252. https:\/\/doi.org\/10.1161\/01.HYP.0000107251.49515.C2","DOI":"10.1161\/01.HYP.0000107251.49515.C2"},{"key":"8338_CR19","doi-asserted-by":"publisher","unstructured":"De Loera-Rodriguez CO, Delgado-Rizo V, Alvarado-Navarro A et al (2014) Over-expression of TLR4-CD14, pro-inflammatory cytokines, metabolic markers and NEFAs in obese non-diabetic Mexicans. J Inflamm (Lond) 11. https:\/\/doi.org\/10.1186\/S12950-014-0039-Y","DOI":"10.1186\/S12950-014-0039-Y"},{"key":"8338_CR20","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1111\/J.2047-6310.2012.00098.X","volume":"8","author":"OT Hardy","year":"2013","unstructured":"Hardy OT, Kim A, Ciccarelli C et al (2013) Increased toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents. Pediatr Obes 8:e19\u2013e23. https:\/\/doi.org\/10.1111\/J.2047-6310.2012.00098.X","journal-title":"Pediatr Obes"},{"key":"8338_CR21","doi-asserted-by":"publisher","first-page":"900","DOI":"10.2337\/DC11-2375","volume":"35","author":"I Jialal","year":"2012","unstructured":"Jialal I, Huet BA, Kaur H et al (2012) Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care 35:900\u2013904. https:\/\/doi.org\/10.2337\/DC11-2375","journal-title":"Diabetes Care"},{"key":"8338_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/DC09-1799","volume":"33","author":"MR Dasu","year":"2010","unstructured":"Dasu MR, Devaraj S, Park S, Jialal I (2010) Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33:861\u2013868. https:\/\/doi.org\/10.2337\/DC09-1799","journal-title":"Diabetes Care"},{"key":"8338_CR23","doi-asserted-by":"publisher","unstructured":"Ahmad R, Al-Mass A, Atizado V et al (2012) Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation. J Inflamm (Lond) 9. https:\/\/doi.org\/10.1186\/1476-9255-9-48","DOI":"10.1186\/1476-9255-9-48"},{"key":"8338_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2014.00461","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2014.00461. 5:","journal-title":"Front Immunol"},{"key":"8338_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000191413","volume":"1","author":"C Erridge","year":"2009","unstructured":"Erridge C (2009) The roles of toll-like receptors in atherosclerosis. J Innate Immun 1:340\u2013349. https:\/\/doi.org\/10.1159\/000191413","journal-title":"J Innate Immun"},{"key":"8338_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1385\/IR:34:3:193","volume":"34","author":"AE Mullick","year":"2006","unstructured":"Mullick AE, Tobias PS, Curtiss LK (2006) Toll-like receptors and atherosclerosis: key contributors in disease and health? Immunol Res 34:193\u2013209. https:\/\/doi.org\/10.1385\/IR:34:3:193","journal-title":"Immunol Res"},{"key":"8338_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1139\/Y11-071","volume":"89","author":"M Hasu","year":"2011","unstructured":"Hasu M, Thabet M, Tam N, Whitman SC (2011) Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice. Can J Physiol Pharmacol 89:737\u2013742. https:\/\/doi.org\/10.1139\/Y11-071","journal-title":"Can J Physiol Pharmacol"},{"key":"8338_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1677\/JOE-08-0354","volume":"199","author":"AM Caricilli","year":"2008","unstructured":"Caricilli AM, Nascimento PH, Pauli JR et al (2008) Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J Endocrinol 199:399\u2013406. https:\/\/doi.org\/10.1677\/JOE-08-0354","journal-title":"J Endocrinol"},{"key":"8338_CR29","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/S00125-010-1747-3","volume":"53","author":"JA Ehses","year":"2010","unstructured":"Ehses JA, Meier DT, Wueest S et al (2010) Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia 53:1795\u20131806. https:\/\/doi.org\/10.1007\/S00125-010-1747-3","journal-title":"Diabetologia"},{"key":"8338_CR30","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2337\/DB20-0591","volume":"70","author":"Z Guo","year":"2021","unstructured":"Guo Z, Zhang Y, Liu C et al (2021) Toll-like receptor 2 (TLR2) knockout abrogates Diabetic and obese phenotypes while restoring endothelial function via inhibition of NOX1. Diabetes 70:2107\u20132119. https:\/\/doi.org\/10.2337\/DB20-0591","journal-title":"Diabetes"},{"key":"8338_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/J.DIABRES.2004.11.007","volume":"69","author":"HS Park","year":"2005","unstructured":"Park HS, Park JY, Yu R (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69:29\u201335. https:\/\/doi.org\/10.1016\/J.DIABRES.2004.11.007","journal-title":"Diabetes Res Clin Pract"},{"key":"8338_CR32","first-page":"4","volume":"17","author":"J-P Bastard","year":"2006","unstructured":"Bastard J-P, Maachi M, Lagathu C et al (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:4\u201312","journal-title":"Eur Cytokine Netw"},{"key":"8338_CR33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/SJ.IJO.0801792","volume":"25","author":"A Festa","year":"2001","unstructured":"Festa A, D\u2019Agostino R, Williams K et al (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25:1407\u20131415. https:\/\/doi.org\/10.1038\/SJ.IJO.0801792","journal-title":"Int J Obes Relat Metab Disord"},{"key":"8338_CR34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/OBY.2003.74","volume":"11","author":"M Bull\u00f3","year":"2003","unstructured":"Bull\u00f3 M, Garc\u00eda-Lorda P, Megias I, Salas-Salvad\u00f3 J (2003) Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 11:525\u2013531. https:\/\/doi.org\/10.1038\/OBY.2003.74","journal-title":"Obes Res"},{"key":"8338_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13813450802181047","volume":"114","author":"I Nieto-Vazquez","year":"2008","unstructured":"Nieto-Vazquez I, Fern\u00e1ndez-Veledo S, Kr\u00e4mer DK et al (2008) Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 114:183\u2013194. https:\/\/doi.org\/10.1080\/13813450802181047","journal-title":"Arch Physiol Biochem"},{"key":"8338_CR36","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/SJ.IJO.0803304","volume":"30","author":"MJ Shin","year":"2006","unstructured":"Shin MJ, Hyun YJ, Kim OY et al (2006) Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 30:1529\u20131534. https:\/\/doi.org\/10.1038\/SJ.IJO.0803304","journal-title":"Int J Obes (Lond)"},{"key":"8338_CR37","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1210\/JC.2014-3885","volume":"100","author":"CH Jung","year":"2015","unstructured":"Jung CH, Lee MJ, Kang YM et al (2015) The risk of incident type 2 diabetes in a korean metabolically healthy obese population: the role of systemic inflammation. J Clin Endocrinol Metab 100:934\u2013941. https:\/\/doi.org\/10.1210\/JC.2014-3885","journal-title":"J Clin Endocrinol Metab"},{"key":"8338_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/J.METABOL.2019.01.003","volume":"93","author":"M Kouvari","year":"2019","unstructured":"Kouvari M, Panagiotakos DB, Yannakoulia M et al (2019) Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the ATTICA cohort study. Metabolism 93:18\u201324. https:\/\/doi.org\/10.1016\/J.METABOL.2019.01.003","journal-title":"Metabolism"},{"key":"8338_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/ENDREV\/BNAA004","volume":"41","author":"M Bl\u00fcher","year":"2020","unstructured":"Bl\u00fcher M (2020) Metabolically healthy obesity. Endocr Rev 41:405\u2013420. https:\/\/doi.org\/10.1210\/ENDREV\/BNAA004","journal-title":"Endocr Rev"},{"key":"8338_CR40","doi-asserted-by":"publisher","unstructured":"Cobos-Palacios L, Ruiz-Moreno MI, Vilches-Perez A et al (2022) Metabolically healthy obesity: inflammatory biomarkers and adipokines in elderly population. PLoS ONE 17. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0265362","DOI":"10.1371\/JOURNAL.PONE.0265362"},{"key":"8338_CR41","doi-asserted-by":"publisher","unstructured":"Agius R, Pace NP, Fava S (2022) Reduced leukocyte mitochondrial copy number in metabolic syndrome and metabolically healthy obesity. Front Endocrinol (Lausanne) 13. https:\/\/doi.org\/10.3389\/FENDO.2022.886957","DOI":"10.3389\/FENDO.2022.886957"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08338-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T16:53:55Z","timestamp":1682700835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08338-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["8338"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08338-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,11]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}